Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy of CD07223 1.5% Gel and 0.5% gel in
reducing inflammatory, non-inflammatory, and total acne lesion counts after 6 weeks of twice
daily applications. The study will also evaluate the safety of the study products using
tolerance and adverse event data.
Phase:
Phase 2
Details
Lead Sponsor:
Galderma Galderma R&D
Treatments:
Adapalene Adapalene, Benzoyl Peroxide Drug Combination Benzoyl Peroxide